Cerchietti 2000.
Study characteristics | ||
Methods | Randomised, comparative prospective, single‐centre trial Method of randomisation: unclear Blinding status: unclear Study duration: 48 hours | |
Participants | Prognosis ‐ terminal‐stage advanced cancer patients ≥ 1 of the following symptoms: thirst; chronic nausea or delirium; dehydration diagnosed on physical examination, with or without renal failure; and inability to maintain an adequate water intake (< 50 mL/day fluid) Sample size: 50 Exclusions: 4 uncontrolled symptoms (pain in 2, severe dyspnoea in 2), 1 bowel obstruction syndrome requiring surgery, 3 severe constipation Participants were recruited from Argentina. |
|
Interventions | 42 participants were randomised to 1 of 2 groups.
|
|
Outcomes | Primary outcomes (VAS):
Secondary outcomes:
|
|
Identification | ||
Notes | No conflicts of interest declared. No grants or support reported. |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Quote: "randomly assigned", but method not adequately described. Comment: unclear if done |
Allocation concealment (selection bias) | Unclear risk | Method used was not described. Comment: unclear if done |
Blinding of participants and personnel (performance bias) All outcomes | Unclear risk | No blinding described. Comment: unclear if done |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | No blinding described. Comment: unclear if done |
Incomplete outcome data (attrition bias) All outcomes | Unclear risk | Method not described. Comment: unclear if done |
Selective reporting (reporting bias) | Unclear risk | Insufficient information presented. Comment: unclear if done |